The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer
Qiuping Xu, Yinyin Deng, Yuping Cai, Shaobin Yu, Mingqiang Kang, Fei He · 2026
Read The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer by Qiuping Xu, Yinyin Deng, Yuping Cai, Shaobin Yu, Mingqiang Kang, Fei He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473555.txt.
Description
Qiuping Xu and five colleagues tested in 2026 whether two cheap blood markers can predict survival in non-small cell lung cancer. Inflammation shapes cancer outcomes, yet simple, low-cost prognostic tools remain valuable. The cohort included 748 consecutive Chinese patients. Relationships between markers, tumour features, and survival were examined through chi-squared tests, Cox regression, and spline models, with survival estimated by Kaplan-Meier curves.
Two markers stood out independently: the systemic inflammation response index, with a hazard ratio of 1.506, and the albumin-to-globulin ratio, with a hazard ratio of 0.749, meaning higher values of the first and lower values of the second went with worse survival. Combining them into a three-tier score separated risk sharply, with the highest-risk group facing a hazard ratio of 1.974. Predictive accuracy held steady near an area under the curve of 0.70. The authors offer the score as a convenient aid for risk stratification.
Catalog record
| CREATOR | Qiuping Xu, Yinyin Deng, Yuping Cai, Shaobin Yu, Mingqiang Kang, Fei He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |